Integrated analysis of CVD risk in HIV: gut microbiota, immune function and metabolites

Medicine & Life Sciences

1. Gastrointestinal Microbiome 100%
2. HIV 75%
3. Metabolomics 35%
4. HIV Infections 28%
5. Atherosclerosis 26%
6. Monocytes 17%
7. Cohort Studies 14%
8. Metagenomics 13%
9. Inflammation 12%
10. Preliminary Data 11%
11. Tryptophan 11%
12. CD4 Lymphocyte Count 10%
13. Carotid Arteries 10%
14. Viral Load 10%
15. Multicenter Studies 9%
16. Acquired Immunodeficiency Syndrome 8%
17. Disease Progression 8%
18. Comorbidity 8%
19. Ultrasonography 8%
20. Biomarkers 6%
21. T-Lymphocytes 6%